<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101465400</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34171</journal-id>
<journal-id journal-id-type="nlm-ta">Sci Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Signal</journal-id>
<journal-title-group>
<journal-title>Science signaling</journal-title>
</journal-title-group>
<issn pub-type="ppub">1945-0877</issn>
<issn pub-type="epub">1937-9145</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31289211</article-id>
<article-id pub-id-type="pmc">7285885</article-id>
<article-id pub-id-type="doi">10.1126/scisignal.aaw3921</article-id>
<article-id pub-id-type="manuscript">NIHMS1593284</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ozaki</surname>
<given-names>Kakeru</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamada</surname>
<given-names>Takanori</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horie</surname>
<given-names>Tetsuhiro</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishizaki</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hiraiwa</surname>
<given-names>Manami</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iezaki</surname>
<given-names>Takashi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Gyujin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fukasawa</surname>
<given-names>Kazuya</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamada</surname>
<given-names>Hikari</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tokumura</surname>
<given-names>Kazuya</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Motono</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaneda</surname>
<given-names>Katsuyuki</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogawa</surname>
<given-names>Kazuma</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ochi</surname>
<given-names>Hiroki</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sato</surname>
<given-names>Shingo</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>Yasuhiro</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Yun-Bo</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>Peter M.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hinoi</surname>
<given-names>Eiichi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">†</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Laboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa 920-1192, Japan.</aff>
<aff id="A2"><label>2</label>Laboratory of Clinical Analytical Sciences, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa 920-1192, Japan.</aff>
<aff id="A3"><label>3</label>Venture Business Laboratory, Organization of Frontier Science and Innovation, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan.</aff>
<aff id="A4"><label>4</label>Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan.</aff>
<aff id="A5"><label>5</label>Department of Physiology and Cell Biology, Tokyo Medical and Dental University, Graduate School, Tokyo 113-8510, Japan.</aff>
<aff id="A6"><label>6</label>Institute for Oral Science, Matsumoto Dental University, Shiojiri, Nagano 399-0781, Japan.</aff>
<aff id="A7"><label>7</label>Section on Molecular Morphogenesis, Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892, USA.</aff>
<aff id="A8"><label>8</label>Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1"><bold>Author contributions:</bold> E.H. conceived and designed the study. K. Ozaki, T.Y., M.H., K.F., and H.K. performed in vivo experiments. K. Ozaki, T.H., A.I., T.I., G.P., K.T., and M.M. performed in vitro experiments. K.K., K. Ogawa, H.O., S.S., Y.K., Y.-B.S., and P.M.T. discussed the results, conceived some experiments, and provided critical reagents and comments. E.H. wrote the manuscript. All authors discussed the results and commented on the manuscript.</p>
</fn>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p id="P2">These authors equally contributed to this work.</p>
</fn>
<corresp id="CR1"><label>†</label>Corresponding author. <email>hinoi@p.kanazawa-u.ac.jp</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P44"><bold>Competing interests:</bold> The authors declare that they have no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<day>09</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>09</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>589</issue>
<elocation-id>eaaw3921</elocation-id>
<abstract id="ABS1">
<p id="P3">L-type amino acid transporter 1 (LAT1), which is encoded by <italic>solute carrier transporter 7a5</italic> (<italic>Slc7a5</italic>), plays a crucial role in amino acid sensing and signaling in specific cell types, contributing to the pathogenesis of cancer and neurological disorders. Amino acid substrates of LAT1 have a beneficial effect on bone health directly and indirectly, suggesting a potential role for LAT1 in bone homeostasis. Here, we identified LAT1 in osteoclasts as important for bone homeostasis. <italic>Slc7a5</italic> expression was substantially reduced in osteoclasts in a mouse model of ovariectomy-induced osteoporosis. The osteoclast-specific deletion of <italic>Slc7a5</italic> in mice led to osteoclast activation and bone loss in vivo, and <italic>Slc7a5</italic> deficiency increased osteoclastogenesis in vitro. Loss of <italic>Slc7a5</italic> impaired activation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway in osteoclasts, whereas genetic activation of mTORC1 corrected the enhanced osteoclastogenesis and bone loss in <italic>Slc7a5</italic>-deficient mice. Last, <italic>Slc7a5</italic> deficiency increased the expression of nuclear factor of activated T cells, cytoplasmic 1 (<italic>Nfatc1</italic>) and the nuclear accumulation of NFATc1, a master regulator of osteoclast function, possibly through the canonical nuclear factor κB pathway and the Akt–glycogen synthase kinase 3β signaling axis, respectively. These findings suggest that the LAT1-mTORC1 axis plays a pivotal role in bone resorption and bone homeostasis by modulating NFATc1 in osteoclasts, thereby providing a molecular connection between amino acid intake and skeletal integrity.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>